Designed by CHAIRONE
-
AbClon Inc. #1401 285, Digital-ro, Guro-gu, Seoul, Republic of Korea
T. +82-2109-1294
F. +82-2109-1296
E. abclon@abclon.com
AbClon’s strong foundations and innovative platforms will help drive the future of
personalized medicine and safeguard the health and hopes of families.
| 제목 | First patient dosed in Phase 1 clinical trial (10:05 AM) | |||||
| 첨부파일 | - | 날짜 | 2022-05-17 | 조회 | 243 | |
|
N/A
|
||||||